Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 693

1.

Use of a Lighted Stent by Near-Infrared Observation to Identify the Urethra During Transanal Total Mesorectal Excision.

Watanabe J, Suwa Y, Suwa H, Ishibe A, Ota M, Kunisaki C, Endo I.

Dis Colon Rectum. 2020 Feb;63(2):256-257. doi: 10.1097/DCR.0000000000001479. No abstract available.

PMID:
31914117
2.

Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium.

Sahara K, Tsilimigras DI, Maithel SK, Abbott DE, Poultsides GA, Hatzaras I, Fields RC, Weiss M, Scoggins C, Isom CA, Idrees K, Shen P, Endo I, Pawlik TM; and the US Extrahepatic Biliary Malignancy Consortium.

J Surg Oncol. 2020 Jan 6. doi: 10.1002/jso.25825. [Epub ahead of print]

PMID:
31907941
3.

Hospital variation in Textbook Outcomes following curative-intent resection of hepatocellular carcinoma: an international multi-institutional analysis.

Tsilimigras DI, Mehta R, Merath K, Bagante F, Paredes AZ, Farooq A, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Grigorie R, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

HPB (Oxford). 2019 Dec 27. pii: S1365-182X(19)33221-6. doi: 10.1016/j.hpb.2019.12.005. [Epub ahead of print]

PMID:
31889626
4.

Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.

Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho C, Beems M, Dillhoff M, Maithel SK, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Dec 14. doi: 10.1245/s10434-019-08120-1. [Epub ahead of print]

PMID:
31838609
5.

Development and validation of a real-time mortality risk calculator before, during and after hepatectomy: an analysis of the ACS NSQIP database.

Sahara K, Tsilimigras DI, Paredes AZ, Farooq SA, Hyer JM, Moro A, Mehta R, Wu L, Endo I, Ejaz A, Cloyd J, Pawlik TM.

HPB (Oxford). 2019 Dec 4. pii: S1365-182X(19)33190-9. doi: 10.1016/j.hpb.2019.10.2446. [Epub ahead of print]

PMID:
31812552
6.

Autonomic Nerve-Preserving Lymph Node Dissection for Lateral Pelvic Lymph Node Metastasis of the Pelvic Floor Using the Transanal Approach.

Watanabe J, Ishibe A, Suwa Y, Suwa H, Ota M, Kunisaki C, Endo I.

Dis Colon Rectum. 2020 Jan;63(1):113-114. doi: 10.1097/DCR.0000000000001478. No abstract available.

PMID:
31804273
7.

Plasma and tumoral glypican-3 levels are correlated in patients with hepatitis C virus-related hepatocellular carcinoma.

Shimizu Y, Mizuno S, Fujinami N, Suzuki T, Saito K, Konishi M, Takahashi S, Gotohda N, Tada T, Toyoda H, Kumada T, Miura M, Suto K, Yamaji T, Matsuda T, Endo I, Nakatsura T.

Cancer Sci. 2019 Nov 27. doi: 10.1111/cas.14251. [Epub ahead of print]

8.

Impact of Preoperative Cholangitis on Short-term Outcomes Among Patients Undergoing Liver Resection.

Sahara K, Merath K, Hyer JM, Paredes AZ, Tsilimigras DI, Mehta R, Farooq SA, Moro A, Wu L, White S, Endo I, Pawlik TM.

J Gastrointest Surg. 2019 Nov 19. doi: 10.1007/s11605-019-04430-7. [Epub ahead of print]

PMID:
31745898
9.

A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients.

Tsilimigras DI, Mehta R, Moris D, Sahara K, Bagante F, Paredes AZ, Moro A, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Nov 14. doi: 10.1245/s10434-019-08067-3. [Epub ahead of print]

PMID:
31728792
10.

Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.

Tsilimigras DI, Mehta R, Moris D, Sahara K, Bagante F, Paredes AZ, Farooq A, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Grigorie R, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Nov 6. doi: 10.1245/s10434-019-08025-z. [Epub ahead of print]

PMID:
31696396
11.

Efficacy of prolonged elemental diet therapy after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A pilot prospective randomized trial (UMIN000004108).

Mori R, Matsuyama R, Taniguchi K, Goto K, Miyake K, Hiratani S, Homma Y, Ohta Y, Kumamoto T, Morioka D, Endo I.

Clin Nutr ESPEN. 2019 Dec;34:116-124. doi: 10.1016/j.clnesp.2019.07.017. Epub 2019 Aug 17.

PMID:
31677701
12.

Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma.

Hiroshima Y, Kasajima R, Kimura Y, Komura D, Ishikawa S, Ichikawa Y, Bouvet M, Yamamoto N, Oshima T, Morinaga S, Singh SR, Hoffman RM, Endo I, Miyagi Y.

Cancer Lett. 2020 Jan 28;469:217-227. doi: 10.1016/j.canlet.2019.10.031. Epub 2019 Oct 24.

PMID:
31669204
13.

Adult onset of Immunoglobulin A vasculitis - A case report.

Yagi S, Endo I, Murakami T, Hida T, Yamamoto Y, Soga T, Ise T, Kusunose K, Yamaguchi K, Fukuda D, Yamada H, Soeki T, Wakatsuki T, Kawahito S, Sata M.

J Med Invest. 2019;66(3.4):344-346. doi: 10.2152/jmi.66.344.

14.

Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.

Tsilimigras DI, Bagante F, Moris D, Merath K, Paredes AZ, Sahara K, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

Surgery. 2019 Dec;166(6):967-974. doi: 10.1016/j.surg.2019.08.010. Epub 2019 Oct 9.

PMID:
31606196
15.

Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells.

Tsuchiya N, Zhang R, Iwama T, Ueda N, Liu T, Tatsumi M, Sasaki Y, Shimoda R, Osako Y, Sawada Y, Kubo Y, Miyashita A, Fukushima S, Cheng Z, Nakaki R, Takubo K, Okada S, Kaneko S, Ihn H, Kaisho T, Nishimura Y, Senju S, Endo I, Nakatsura T, Uemura Y.

Cell Rep. 2019 Oct 1;29(1):162-175.e9. doi: 10.1016/j.celrep.2019.08.086.

16.

Conditional disease-free survival after curative-intent liver resection for neuroendocrine liver metastasis.

Sahara K, Merath K, Tsilimigras DI, Hyer JM, Guglielmi A, Aldrighetti L, Weiss M, Fields RC, Poultsides GA, Maithel SK, Endo I, Pawlik TM, Other Members Of The U S Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(7):1087-1095. doi: 10.1002/jso.25713. Epub 2019 Sep 24.

PMID:
31550406
17.

Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgical Resection.

Kubo H, Murakami T, Matsuyama R, Yabushita Y, Tsuchiya N, Sawada Y, Homma Y, Kumamoto T, Endo I.

World J Surg. 2019 Dec;43(12):3153-3160. doi: 10.1007/s00268-019-05159-9.

PMID:
31549202
18.

Curative-Intent Surgery for Stage IV Advanced Gastric Cancer: Who Can Undergo Surgery and What Are the Prognostic Factors for Long-Term Survival?

Sato S, Kunisaki C, Tanaka Y, Sato K, Miyamoto H, Yukawa N, Kosaka T, Akiyama H, Endo I, Misumi T.

Ann Surg Oncol. 2019 Dec;26(13):4452-4463. doi: 10.1245/s10434-019-07790-1. Epub 2019 Sep 16.

PMID:
31529308
19.

Survey of preoperative management protocol for perihilar cholangiocarcinoma at 10 Japanese high-volume centers with a combined experience of 2,778 cases.

Chaudhary RJ, Higuchi R, Nagino M, Unno M, Ohtsuka M, Endo I, Hirano S, Uesaka K, Hasegawa K, Wakai T, Uemoto S, Yamamoto M.

J Hepatobiliary Pancreat Sci. 2019 Nov;26(11):490-502. doi: 10.1002/jhbp.668. Epub 2019 Oct 10.

PMID:
31520452
20.

MiR-194-5p in Pancreatic Ductal Adenocarcinoma Peritoneal Washings is Associated with Peritoneal Recurrence and Overall Survival in Peritoneal Cytology-Negative Patients.

Kubo H, Hiroshima Y, Mori R, Saigusa Y, Murakami T, Yabushita Y, Sawada Y, Homma Y, Kumamoto T, Matsuyama R, Endo I.

Ann Surg Oncol. 2019 Dec;26(13):4506-4514. doi: 10.1245/s10434-019-07793-y. Epub 2019 Sep 5.

PMID:
31489551
21.

The risk factors for urinary dysfunction after autonomic nerve-preserving rectal cancer surgery: a multicenter retrospective study at Yokohama Clinical Oncology Group (YCOG1307).

Toritani K, Watanabe J, Suwa Y, Suzuki S, Nakagawa K, Suwa H, Ishibe A, Ota M, Kunisaki C, Endo I.

Int J Colorectal Dis. 2019 Oct;34(10):1697-1703. doi: 10.1007/s00384-019-03374-3. Epub 2019 Aug 30.

PMID:
31471695
22.

Discordance in prediction of prognosis among patients with intrahepatic cholangiocarcinoma: A preoperative vs postoperative perspective.

Moro A, Paredes AZ, Farooq A, Sahara K, Tsilimigras DI, Mehta R, Endo I, Guglielmi A, Aldrighetti L, Alexandrescu S, Marques HP, Shen F, Koerkamp BG, Sasaki K, Pawlik TM; other members of the International Intrahepatic Cholangiocarcinoma Study Group.

J Surg Oncol. 2019 Nov;120(6):946-955. doi: 10.1002/jso.25671. Epub 2019 Aug 13.

PMID:
31410852
23.

High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.

Murakami T, Matsuyama R, Ueda M, Mochizuki Y, Homma Y, Kameda K, Yazawa K, Izumisawa Y, Fukushima T, Kamimukai N, Yoshida K, Kamiya N, Hoffman RM, Endo I.

World J Surg Oncol. 2019 Aug 9;17(1):140. doi: 10.1186/s12957-019-1675-8.

24.

Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial.

Shimizu Y, Yoshikawa T, Kojima T, Shoda K, Nosaka K, Mizuno S, Wada S, Fujimoto Y, Sasada T, Kohashi K, Bando H, Endo I, Nakatsura T.

Cancer Sci. 2019 Oct;110(10):3049-3060. doi: 10.1111/cas.14165. Epub 2019 Sep 19.

25.

The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.

Margonis GA, Amini N, Buettner S, Kim Y, Wang J, Andreatos N, Wagner D, Sasaki K, Beer A, Kamphues C, Morioka D, Løes IM, Imai K, He J, Pawlik TM, Kaczirek K, Poultsides G, Lønning PE, Burkhart R, Endo I, Baba H, Mischinger HJ, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ.

Ann Surg. 2019 Aug 5. doi: 10.1097/SLA.0000000000003504. [Epub ahead of print]

PMID:
31389831
26.

Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404).

Nakagawa K, Watanabe J, Ota M, Suwa Y, Suzuki S, Suwa H, Momiyama M, Ishibe A, Saigusa Y, Yamanaka T, Kunisaki C, Endo I.

Surg Today. 2020 Jan;50(1):68-75. doi: 10.1007/s00595-019-01859-w. Epub 2019 Aug 5.

PMID:
31385041
27.

Potential disease burden of patients with substance abuse undergoing major abdominal surgery: A propensity score-matched analysis.

Sahara K, Paredes AZ, Mehta R, Hyer JM, Tsilimigras DI, Merath K, Farooq SA, Wu L, Moro A, Beal EW, Endo I, Pawlik TM.

Surgery. 2019 Dec;166(6):1181-1187. doi: 10.1016/j.surg.2019.06.018. Epub 2019 Aug 2.

PMID:
31378476
28.

Outcome of postoperative radiation therapy for cholangiocarcinoma and analysis of dose-volume histogram of remnant liver.

Mukai Y, Matsuyama R, Koike I, Kumamoto T, Kaizu H, Homma Y, Takano S, Sawada Y, Sugiura M, Yabushita Y, Ito E, Sato M, Endo I, Hata M.

Medicine (Baltimore). 2019 Aug;98(31):e16673. doi: 10.1097/MD.0000000000016673.

29.

Persistent Activation of Calcium-Sensing Receptor Suppresses Bone Turnover, Increases Microcracks, and Decreases Bone Strength.

Dong B, Endo I, Ohnishi Y, Mitsui Y, Kurahashi K, Kanai M, Hiasa M, Teramachi J, Tenshin H, Fukumoto S, Abe M, Matsumoto T.

JBMR Plus. 2019 Mar 6;3(7):e10182. doi: 10.1002/jbm4.10182. eCollection 2019 Jul.

30.

Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy and Curative Resection.

Tsuchiya N, Matsuyama R, Murakami T, Yabushita Y, Sawada YU, Kumamoto T, Endo I.

Anticancer Res. 2019 Aug;39(8):4431-4440. doi: 10.21873/anticanres.13615.

PMID:
31366541
31.

High-signal-intensity MR Image in the Hepatobiliary Phase Predicts Long-term Survival in Patients With Hepatocellular Carcinoma.

Ariizumi SI, Ban D, Abe Y, Kumamoto T, Koizumi S, Tanabe M, Shinoda M, Endo I, Otsubo T, Yamamoto M.

Anticancer Res. 2019 Aug;39(8):4219-4225. doi: 10.21873/anticanres.13583.

PMID:
31366509
32.

Clinical analysis of preoperative deep vein thrombosis risk factors in patients with colorectal cancer: Retrospective observational study.

Nakagawa K, Watanabe J, Suwa Y, Suzuki S, Ishibe A, Ota M, Kunisaki C, Endo I.

Ann Gastroenterol Surg. 2019 Apr 29;3(4):451-458. doi: 10.1002/ags3.12256. eCollection 2019 Jul.

33.

Surgical outcomes of gastroenterological surgery in Japan: Report of the National Clinical Database 2011-2017.

Hasegawa H, Takahashi A, Kakeji Y, Ueno H, Eguchi S, Endo I, Sasaki A, Takiguchi S, Takeuchi H, Hashimoto M, Horiguchi A, Masaki T, Marubashi S, Yoshida K, Konno H, Gotoh M, Miyata H, Seto Y.

Ann Gastroenterol Surg. 2019 May 20;3(4):426-450. doi: 10.1002/ags3.12258. eCollection 2019 Jul.

34.

Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.

Bagante F, Spolverato G, Merath K, Weiss M, Alexandrescu S, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Guglielmi A, Endo I, Pawlik TM.

Surgery. 2019 Dec;166(6):983-990. doi: 10.1016/j.surg.2019.06.005. Epub 2019 Jul 17.

PMID:
31326191
35.

Impact of Surgeon Volume on Outcomes and Expenditure Among Medicare Beneficiaries Undergoing Liver Resection: the Effect of Minimally Invasive Surgery.

Sahara K, Merath K, Hyer JM, Tsilimigras DI, Paredes AZ, Farooq A, Mehta R, Wu L, Beal EW, White S, Endo I, Pawlik TM.

J Gastrointest Surg. 2019 Jul 19. doi: 10.1007/s11605-019-04323-9. [Epub ahead of print]

PMID:
31325139
36.

The efficacy of a trauma call system: challenges in managing severe trauma at a rural emergency center without full-time emergency physicians.

Matsumoto N, Yamamoto S, Endo I, Yoshida O, Kubo M, Udaka T, Sogabe O, Maeda H, Kawata C, Kurokawa H.

Acute Med Surg. 2019 Mar 12;6(3):259-264. doi: 10.1002/ams2.406. eCollection 2019 Jul.

37.

Additional Surgical Resection After Endoscopic Resection for Patients With High-risk T1 Colorectal Cancer.

Iguchi K, Mushiake H, Aoyama T, Suwa H, Yukawa N, Ota M, Rino Y, Kunisaki C, Endo I, Masuda M.

In Vivo. 2019 Jul-Aug;33(4):1243-1248. doi: 10.21873/invivo.11596.

38.

Predictive model for survival after liver resection for noncolorectal liver metastases in the modern era: a Japanese multicenter analysis.

Wakabayashi T, Hibi T, Yoneda G, Iwao Y, Sawada Y, Hoshino H, Uemura S, Ban D, Kudo A, Takemura Y, Mishima K, Shinoda M, Itano O, Otsubo T, Endo I, Kitagawa Y, Tanabe M, Egawa H, Yamamoto M.

J Hepatobiliary Pancreat Sci. 2019 Oct;26(10):441-448. doi: 10.1002/jhbp.654. Epub 2019 Jul 28.

PMID:
31271511
39.

Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.

Tsilimigras DI, Bagante F, Sahara K, Moris D, Hyer JM, Wu L, Ratti F, Marques HP, Soubrane O, Paredes AZ, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Oct;26(11):3693-3700. doi: 10.1245/s10434-019-07580-9. Epub 2019 Jul 2.

PMID:
31267302
40.

Matrix-producing Carcinoma as an Aggressive Triple-negative Breast Cancer: Clinicopathological Features and Response to Neoadjuvant Chemotherapy.

Shimada K, Ishikawa T, Yamada A, Sugae S, Narui K, Shimizu D, Chishima T, Endo I.

Anticancer Res. 2019 Jul;39(7):3863-3869. doi: 10.21873/anticanres.13536.

PMID:
31262914
41.

Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.

Tsilimigras DI, Sahara K, Moris D, Hyer JM, Paredes AZ, Bagante F, Merath K, Farooq AS, Ratti F, Marques HP, Soubrane O, Azoulay D, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

J Gastrointest Surg. 2019 Jun 26. doi: 10.1007/s11605-019-04275-0. [Epub ahead of print]

PMID:
31243714
42.

Abdominal drainage may be a risk factor for surgical site infection following appendectomy.

Murakami T, Wada T, Ishibe A, Akiyama H, Endo I.

Asian J Surg. 2019 Sep;42(9):897-898. doi: 10.1016/j.asjsur.2019.05.007. Epub 2019 Jun 21. No abstract available.

43.

Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101.

Narui K, Ishikawa T, Shimizu D, Yamada A, Tanabe M, Sasaki T, Oba MS, Morita S, Nawata S, Kida K, Mogaki M, Doi T, Tsugawa K, Ogata H, Ota T, Kosaka Y, Sengoku N, Kuranami M, Niikura N, Saito Y, Suzuki Y, Suto A, Arioka H, Chishima T, Ichikawa Y, Endo I, Tokuda Y.

Breast. 2019 Oct;47:1-9. doi: 10.1016/j.breast.2019.06.003. Epub 2019 Jun 15.

PMID:
31229857
44.

Efficacy of Tumor-Targeting Salmonella typhimurium A1-R against Malignancies in Patient-Derived Orthotopic Xenograft (PDOX) Murine Models.

Murakami T, Hiroshima Y, Miyake K, Kiyuna T, Endo I, Zhao M, Hoffman RM.

Cells. 2019 Jun 16;8(6). pii: E599. doi: 10.3390/cells8060599. Review.

45.

The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model.

Miyake K, Higuchi T, Oshiro H, Zhang Z, Sugisawa N, Park JH, Razmjooei S, Katsuya Y, Barangi M, Li Y, Nelson SD, Murakami T, Homma Y, Hiroshima Y, Matsuyama R, Bouvet M, Chawla SP, Singh SR, Endo I, Hoffman RM.

Biomed Pharmacother. 2019 Sep;117:109093. doi: 10.1016/j.biopha.2019.109093. Epub 2019 Jun 11.

46.

Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey.

Kobayashi S, Beppu T, Honda G, Yamamoto M, Takahashi K, Endo I, Hasegawa K, Kotake K, Itabashi M, Hashiguchi Y, Kotera Y, Sakamoto K, Yamaguchi T, Morita S, Tabuchi K, Miyazaki M, Sugihara K.

J Gastrointest Surg. 2019 Jun 13. doi: 10.1007/s11605-019-04250-9. [Epub ahead of print]

PMID:
31197683
47.

Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation?

Sahara K, Tsilimigras DI, Merath K, Bagante F, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Matsuyama R, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Sep;26(9):2959-2968. doi: 10.1245/s10434-019-07483-9. Epub 2019 May 31.

PMID:
31152272
48.

Looking for the best practice for acute cholecystitis.

Endo I.

Ann Gastroenterol Surg. 2019 May 17;3(3):228-230. doi: 10.1002/ags3.12257. eCollection 2019 May. No abstract available.

49.

Effect of Portal Vein Ligation Plus Venous Congestion on Liver Regeneration in Rats.

Kawaguchi D, Hiroshima Y, Kumamoto T, Mori R, Matsuyama R, Ichikawa Y, Inayama Y, Endo I.

Ann Hepatol. 2019 Jan - Feb;18(1):89-100. doi: 10.5604/01.3001.0012.7866.

50.

Randomized controlled trial to evaluate laparoscopic versus open surgery in transverse and descending colon cancer patients.

Toritani K, Watanabe J, Nakagawa K, Suwa Y, Suwa H, Ishibe A, Ota M, Fujii S, Kunisaki C, Endo I.

Int J Colorectal Dis. 2019 Jul;34(7):1211-1220. doi: 10.1007/s00384-019-03305-2. Epub 2019 May 17.

PMID:
31102008

Supplemental Content

Support Center